2026 · 3rd Quarter (July 1 - Sep 30)

FRESENIUS MEDICAL CARE NORTH AMERICA

Filed by AVENUE SOLUTIONS.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 20, 2026
Income: $60,000.00
Expenses: Not reported
Registrant: AVENUE SOLUTIONS
Client: FRESENIUS MEDICAL CARE NORTH AMERICA
Filing UUID: 56cb183b-0c4f-4968-aeca-942c7bda957f
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Proposed Rule - CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury Dialysis (AKI) Payment, and ESRD Quality Incentive Program; Market Basket Update in CY 2027 ESRD PPS; Low Volume Payment Adjustment eligibility in CY 2027 ESRD PPS; Medicare forecast error adjustment in ESRD PPS

Literal federal measure citations: H.R. 2199, S. 1173, S. 2730, H.R. 6214

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.